The Patent Finder
US

Purified Amniotic Membrane Compositions and Methods of Use

US 9,956,252 Term ended
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Jun 7, 2024 (U.S. Bank Trust Company, National Association).

Term ended Sep 27, 2026 · High confidence

Filed Sep 8, 2015 as application 14/848,143 · Granted May 1, 2018
Base term, 20 years from filing
Today
20 years from filing
Term ended Sep 27, 2026
2006 2026
Clock starts
Sep 27, 2006
Term ended
Sep 27, 2026
Granted
May 1, 2018
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,153,162, US 8,182,840, US 8,182,841, US 8,187,639, US 8,420,126, US 8,440,235, US 8,455,009, US 8,460,714, US 9,161,954, US 9,161,955, US 9,161,956, US 9,198,939, US 9,526,770, to Sep 27, 2026. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 27, 2006, when application 11/528,980, the earliest non-provisional in its chain, was filed (this one was filed Sep 8, 2015)Sep 27, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,153,162, US 8,182,840, US 8,182,841, US 8,187,639, US 8,420,126, US 8,440,235, US 8,455,009, US 8,460,714, US 9,161,954, US 9,161,955, US 9,161,956, US 9,198,939, US 9,526,770)resolves to Sep 27, 2026, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderSep 27, 2026High confidence

This family

US 8,153,162In force
May 2027
May 2027
US 8,460,714Term ended
Sep 2026
Sep 2026
US 9,198,939Term ended
Sep 2026
Sep 2026
US 9,956,252this patent
Sep 2026
Sep 2026
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 4, 2015
Reel 36962, frame 380
Tseng, Scheffer; He, Hua; Li, WeiBio-Tissue, Inc.Assignment of Assignor's Interest
Nov 4, 2015
Reel 36962, frame 403
Bio-Tissue, Inc.Tissuetech, Inc.Assignment of Assignor's Interest
May 18, 2022
Reel 60116, frame 413
Tissuetech, Inc.; Bio-Tissue, Inc.; Amniox Medical, Inc.Midcap Financial TrustIntellectual Property Security Agreement - Term Loan
May 18, 2022
Reel 60116, frame 468
Tissuetech, Inc.; Bio-Tissue, Inc.; Amniox Medical, Inc.Midcap Funding IV TrustIntellectual Property Security Agreement - Revolving Loan
May 10, 2023
Reel 63591, frame 802
Tissuetech, Inc.Biotissue Holdings Inc.Change of Name
Jun 7, 2024
reel/frame not recorded
Midcap Financial TrustBiotissue Holdings Inc. (F/K/A Tissue Tech, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Financial TrustBiotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Financial TrustBiotissue Surgical Inc. (F/K/A Amniox Medical, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Funding IV TrustBiotissue Holdings Inc. (F/K/A Tissue Tech, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Funding IV TrustBiotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.)Release of Security Interest
Jun 7, 2024
reel/frame not recorded
Midcap Funding IV TrustBiotissue Surgical Inc. (F/K/A Amniox Medical, Inc.)Release of Security Interest
Jun 7, 2024
Reel 67666, frame 235
Biotissue Holdings Inc.; Biotissue Ocular Inc.; Biotissue Surgical Inc.U.S. Bank Trust Company, National AssociationSecurity Interest
Jun 7, 2024
Reel 67666, frame 165
Midcap Financial TrustBiotissue Holdings Inc. (F/K/A Tissue Tech, Inc.); Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.); Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.)Release of Security Interest
Jun 7, 2024
Reel 67666, frame 200
Midcap Funding IV TrustBiotissue Holdings Inc. (F/K/A Tissue Tech, Inc.); Biotissue Ocular Inc. (F/K/A Bio-Tissue, Inc.); Biotissue Surgical Inc. (F/K/A Amniox Medical, Inc.)Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited